1st Quarter - Report

THE PETRIZZO GROUP, INC. for FATE THERAPEUTICS, INC.

Period 1st Quarter 2011 Filed Apr 10, 2011 Signed by Thomas J. "T.J." Petrizzo, Chairman & CEO

Official filing
Firm
THE PETRIZZO GROUP, INC.
Client
FATE THERAPEUTICS, INC.
Income
$20,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Advocated for funding to advance from basic research to clinical readiness a first generation stem cell medicine to restore hearing, eyesight, and bone fractures by using the fundemental biological mechanisms that guide cell fate to develop innovative therapeutics. Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health.

LobbyistCovered position, as disclosed
TJ PETRIZZO —

Contacted: Defense Advanced Research Projects Agency (DARPA); HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

Advocated for funding to advance from basic research to clinical readiness a first generation stem cell medicine to restore hearing, eyesight, and bone fractures by using the fundemental biological mechanisms that guide cell fate to develop innovative therapeutics. Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health.

LobbyistCovered position, as disclosed
TJ PETRIZZO —

Contacted: SENATE; Defense Advanced Research Projects Agency (DARPA); HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Advocated for funding to advance from basic research to clinical readiness a first generation stem cell medicine to restore hearing, eyesight, and bone fractures by using the fundemental biological mechanisms that guide cell fate to develop innovative therapeutics. Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health.

LobbyistCovered position, as disclosed
TJ PETRIZZO —

Contacted: HOUSE OF REPRESENTATIVES; Defense Advanced Research Projects Agency (DARPA); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.